A case of isolated cutaneous myeloid sarcoma preceding acute myeloid leukemia and literature review

Isolated Cutaneous Myeloid Sarcoma (icMS) and Aleukemic Leukemia Cutis (ALC) are cutaneous extramedullary manifestations of leukemia in which leukemic cells infiltrate the skin before they can be identified either in the peripheral blood or in the bone marrow. We report the case of a 67-year-old pat...

詳細記述

保存先:
書誌詳細
主要な著者: Konstantina Mavridou (著者), Sofia Gavriil (著者), Alexandra Papoudou-Bai (著者), George Gaitanis (著者), Alexia Piperidou (著者), Ioannis D. Bassukas (著者)
フォーマット: 図書
出版事項: PAGEPress Publications, 2024-10-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2d6ec60eb1a74e659506f1bd7d577d1f
042 |a dc 
100 1 0 |a Konstantina Mavridou  |e author 
700 1 0 |a Sofia Gavriil  |e author 
700 1 0 |a Alexandra Papoudou-Bai  |e author 
700 1 0 |a George Gaitanis  |e author 
700 1 0 |a Alexia Piperidou  |e author 
700 1 0 |a Ioannis D. Bassukas  |e author 
245 0 0 |a A case of isolated cutaneous myeloid sarcoma preceding acute myeloid leukemia and literature review 
260 |b PAGEPress Publications,   |c 2024-10-01T00:00:00Z. 
500 |a 10.4081/dr.2024.10013 
500 |a 2036-7392 
500 |a 2036-7406 
520 |a Isolated Cutaneous Myeloid Sarcoma (icMS) and Aleukemic Leukemia Cutis (ALC) are cutaneous extramedullary manifestations of leukemia in which leukemic cells infiltrate the skin before they can be identified either in the peripheral blood or in the bone marrow. We report the case of a 67-year-old patient who presented with a rapidly developing cutaneous tumour and scaly, erythematous-squamous plaques. Isolated Cutaneous Myeloid Sarcoma was diagnosed which rapidly progressed to terminal-stage Acute Myeloid Leukemia (AML). To highlight the disease characteristics of the adult-onset icMS and ALC cases that preceded AML we additionally compiled the pertinent literature of case reports of these rare conditions. We identified n=15 previously published icMS/ALC cases with adequately detailed clinical data descriptions. We could confirm the medical experience that icMS/ALC patients have an overall worse prognosis. Moreover, we could identify FAB M5 AML subtype as a significant adverse prognosticator of these patients. 
546 |a EN 
690 |a Acute Myeloid Leukemia 
690 |a Aleukemic Leukemia Cutis 
690 |a Myeloid Sarcoma 
690 |a Isolated Cutaneous Myeloid Sarcoma 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Dermatology Reports (2024) 
787 0 |n https://www.pagepress.org/journals/dr/article/view/10013 
787 0 |n https://doaj.org/toc/2036-7392 
787 0 |n https://doaj.org/toc/2036-7406 
856 4 1 |u https://doaj.org/article/2d6ec60eb1a74e659506f1bd7d577d1f  |z Connect to this object online.